BioAtla to Announce First Quarter 2022 Financial Results and Provide Business Highlights on May 4, 2022
April 08, 2022 08:00 ET
|
BioAtla, Inc.
SAN DIEGO, April 08, 2022 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody...